Boltz: Open-Source Generative Protein Structure Prediction and Design with Boltz-1, Boltz-2, and Boltz Lab
While single-chain protein structure prediction had seen dramatic progress, modeling complex molecular interactions—protein-ligand, protein-protein—and enabling generative protein design remained open challenges critical to drug discovery and biology.
Prior regression-based structure prediction models produced averaged outputs when the ground truth was ambiguous between multiple valid conformational states, rather than sampling the full posterior distribution of possible structures.
Boltz released open-source Boltz-1 and Boltz-2 models approaching AlphaFold 3 performance, and launched Boltz Lab—a platform running 10x faster than open-source versions—that achieved nanomolar binders for two-thirds of 9 novel validation targets with zero prior PDB interactions.
Frequently asked questions
What did this team achieve with this AI workflow?
Boltz released open-source Boltz-1 and Boltz-2 models approaching AlphaFold 3 performance, and launched Boltz Lab—a platform running 10x faster than open-source versions—that achieved nanomolar binders for two-thirds…
What tools did this team use?
Boltz-1, Boltz-2, BoltzGen, Boltz Lab, Protein Data Bank.
What results were reported?
Boltz Lab inference speed vs open-source: 10x faster; Nanomolar binders achieved on novel validation targets: two-thirds; novel PDB-zero-interaction targets tested: 9 (source-reported, not independently verified).
What failed first in this deployment?
Prior regression-based structure prediction models produced averaged outputs when the ground truth was ambiguous between multiple valid conformational states, rather than sampling the full posterior distribution of po…
How is this workflow AI workflow structured?
User submits design spec → Unified structure-sequence encoding → Generative structure and sequence decoding → Affinity prediction → Validation on novel targets → Medicinal chemist review.